GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (FRA:2BO) » Definitions » Marketable Securities

Serina Therapeutics (FRA:2BO) Marketable Securities : €0.00 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Serina Therapeutics's Marketable Securities for the quarter that ended in Mar. 2025 was €0.00 Mil.

Serina Therapeutics Marketable Securities Historical Data

The historical data trend for Serina Therapeutics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Marketable Securities Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Marketable Securities
0.88 - - -

Serina Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Serina Therapeutics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Serina Therapeutics  (FRA:2BO) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Serina Therapeutics Marketable Securities Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (FRA:2BO) » Definitions » Marketable Securities
Comparable Companies
VTVT CYCC IKNA VICP NTRB CUE MAIA CTMX PDSB APLT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
SER:USA
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Serina Therapeutics Headlines

No Headlines